Geldanamycin attenuates NO-mediated dilation in human skin.
about
Neuronal nitric oxide synthase control mechanisms in the cutaneous vasculature of humans in vivoAging and the control of human skin blood flowEndothelial nitric oxide synthase control mechanisms in the cutaneous vasculature of humans in vivoTransient receptor potential vanilloid type-1 (TRPV-1) channels contribute to cutaneous thermal hyperaemia in humans.Antagonism of soluble guanylyl cyclase attenuates cutaneous vasodilation during whole body heat stress and local warming in humans.KCa channels and epoxyeicosatrienoic acids: major contributors to thermal hyperaemia in human skin.Preclinical assessment of the efficacy of mycograb, a human recombinant antibody against fungal HSP90Passive heat therapy improves cutaneous microvascular function in sedentary humans via improved nitric oxide-dependent dilation.Cutaneous blood flow and sweat rate responses to exogenous administration of acetylcholine and methacholine.Effects of vehicle microdialysis solutions on cutaneous vascular responses to local heating.Edward F. Adolph Distinguished Lecture: Skin-deep insights into vascular aging.Autoregulation of blood flow: Vessel diameter changes in response to different temperatures.K+ channel mechanisms underlying cholinergic cutaneous vasodilation and sweating in young humans: roles of KCa, KATP, and KV channels?Heat shock protein 90 contributes to cutaneous vasodilation through activating nitric oxide synthase in young male adults exercising in the heat.The roles of KCa, KATP, and KV channels in regulating cutaneous vasodilation and sweating during exercise in the heat.The interactive contributions of Na(+) /K(+) -ATPase and nitric oxide synthase to sweating and cutaneous vasodilatation during exercise in the heat.
P2860
Q24301869-D263F29B-DC96-45CA-BA33-C073376F8942Q28394291-46B7482D-166D-4E92-955D-F0EB39998F3AQ33333379-DAAD9C95-04DF-4F7B-B68C-012E7CD493D3Q33679588-17FAB8D7-F499-406D-A08C-D82B6B264B98Q33811590-BC5B01C5-CD0D-43DD-9F55-952F512DB3C7Q34295215-0BCDD413-CB0A-49DE-8B2F-9D5D6C727D1AQ35102525-68257759-8B1B-4A70-89EB-B4E8B82847EDQ36078362-DB09B7E1-EE15-4BA8-8936-35BD85ED25DCQ36742612-BABA1233-64C0-44D1-94AE-3C86B64AAE38Q38599191-D499DE1A-C629-47E9-AF12-19541398F68FQ39448948-F6450772-04C7-4371-BE6D-666FC2F759E3Q41692189-E28964C6-3E59-491A-8D3D-54C31222C526Q42231635-27F3A01E-7DB6-48A6-A7F5-5CF909A741BEQ48019359-C0709235-34F5-4F9E-9756-1698A2BF4944Q50864445-8098CF78-E193-4DD7-8325-479E3E8D6AE6Q53636152-A8064F2F-84BF-405F-812E-64DD78B76EF7
P2860
Geldanamycin attenuates NO-mediated dilation in human skin.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Geldanamycin attenuates NO-mediated dilation in human skin.
@ast
Geldanamycin attenuates NO-mediated dilation in human skin.
@en
type
label
Geldanamycin attenuates NO-mediated dilation in human skin.
@ast
Geldanamycin attenuates NO-mediated dilation in human skin.
@en
prefLabel
Geldanamycin attenuates NO-mediated dilation in human skin.
@ast
Geldanamycin attenuates NO-mediated dilation in human skin.
@en
P2860
P1476
Geldanamycin attenuates NO-mediated dilation in human skin.
@en
P2093
Michael J Joyner
Shubha Shastry
P2860
P304
P356
10.1152/AJPHEART.2002.282.1.H232
P577
2002-01-01T00:00:00Z